Subclinical hepatitis E virus (HEV) infection detected by nucleic acid amplification test on blood donation: short-term positivity for immunoglobulin G class of antibody against HEV.
Anti-HEV IgG
Blood donation
Hepatitis E virus
Nucleic acid amplification test
Subclinical infection
Journal
Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
18
03
2022
accepted:
11
04
2022
pubmed:
5
5
2022
medline:
2
8
2022
entrez:
4
5
2022
Statut:
ppublish
Résumé
A case of subclinical hepatitis E virus (HEV) infection was detected by nucleic acid amplification test on blood donation. The patient was followed-up until day 220 after the blood donation but showed no symptoms throughout the observation period. Aspartate aminotransferase and alanine aminotransferase levels reached the maximum values on day 37 with a slight increase but remained in normal ranges from day 67 to 220. The quantity of HEV RNA at the initial examination on day 13 was 1.1 × 10
Identifiants
pubmed: 35507275
doi: 10.1007/s12328-022-01635-3
pii: 10.1007/s12328-022-01635-3
doi:
Substances chimiques
Hepatitis Antibodies
0
Immunoglobulin G
0
Immunoglobulin M
0
RNA, Viral
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
750-754Subventions
Organisme : Japan Agency for Medical Research and Development
ID : JP21fk0210075
Informations de copyright
© 2022. Japanese Society of Gastroenterology.
Références
Satake M, Matsubayashi K, Hoshi Y, et al. Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression. Transfusion. 2017;57:280–8.
doi: 10.1111/trf.13994
Tanaka A, Hoshi Y, Hasegawa T, et al. The current status of transfusion-transmitted hepatitis E virus infection in Japan. Jpn J Transfus Cell Ther. 2020;66:531–7.
doi: 10.3925/jjtc.66.531
Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004;44:934–40.
doi: 10.1111/j.1537-2995.2004.03300.x
Sakata H, Matsubayashi K, Iida J, et al. Trends in hepatitis E virus infection: analyses of the long-term screening of blood donors in Hokkaido, Japan, 2005–2019. Transfusion. 2021;61:3390–401.
doi: 10.1111/trf.16700
https://www.jrc.or.jp/donation/blood/news/200803_006282.html . Accessed 14 Mar 2022
Matsubayashi K. News and topics: introduction of HEV NAT screening for blood donors. Med Technol. 2021;49:212–3
Mizuo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol. 2002;40:3209–18.
doi: 10.1128/JCM.40.9.3209-3218.2002
Nakano T, Nishigaki Y, Hayashi H, et al. Classification of hepatitis E virus diffusion patterns inferred by genome analysis: observation of 13 hepatitis E cases in Gifu, Japan. Kanzo. 2022;63:35–8.
doi: 10.2957/kanzo.63.35
Okano H, Takahashi M, Isono Y, et al. Characterization of sporadic acute hepatitis E and comparison of hepatitis E virus genomes in acute hepatitis patients and pig liver sold as food in Mie, Japan. Hepatol Res. 2014;44:E63–E76.
doi: 10.1111/hepr.12216
Smith DB, Izopet J, Nicot F, et al. Update: proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A). J Gen Virol. 2020;101:692–8.
doi: 10.1099/jgv.0.001435
Takahashi M, Yamada K, Hoshino Y, et al. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch Virol. 2008;153:1703–13.
doi: 10.1007/s00705-008-0179-6
Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43:49–56.
doi: 10.1128/JCM.43.1.49-56.2005
Takahashi M, Tamura K, Hoshino Y, et al. A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol. 2010;82:271–81.
doi: 10.1002/jmv.21678
Ishida S, Yoshizumi S, Matsubayashi K, et al. Usefulness of methods to detect hepatitis E virus infection for case notifications. Kanzo. 2019;60:23–30.
doi: 10.2957/kanzo.60.23
Khuroo M, Kamili S, Yousuf Dar M, et al. Hepatitis E and long-term antibody status. The Lancet. 1993;341:1355.
Aggarwal R, Goel A. Natural history, clinical manifestations, and pathogenesis of hepatitis E virus genotype 1 and 2 infections. Cold Spring Harb Perspect Med. 2019;9:a032136.
doi: 10.1101/cshperspect.a032136
Fuse K, Matsuyama Y, Moriyama M, et al. Late onset post-transfusion hepatitis E developing during chemotherapy for acute promyelocytic leukemia. Intern Med. 2015;54:657–61.
doi: 10.2169/internalmedicine.54.2332
Okano H, Nakano T, Ito R, et al. The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion-transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia. Clin J Gastroenterol. 2020;13:252–9.
doi: 10.1007/s12328-019-01024-3
Okano H, Asakawa H, Tsuruga S, et al. A fatal case of exacerbated liver cirrhosis caused by acute hepatitis E virus infection: atypical dynamics of anti-hepatitis E virus antibody titers. Kanzo. 2020;61:326–34.
doi: 10.2957/kanzo.61.326
Abe T, Aikawa T, Akahane Y, et al. Demographic, epidemiological, and virological characteristics of hepatitis E virus infection in Japan based on 254 human cases collected nationwide. Kanzo. 2006;47:384–91.
doi: 10.2957/kanzo.47.384
Takahashi M, Okamoto H. Features of hepatitis E virus infection in humans and animals in Japan. Hepatol Res. 2014;44:43–58.
doi: 10.1111/hepr.12175
Kamar N, Pischke S. Acute and persistent hepatitis E virus genotype 3 and 4 infection: clinical features, pathogenesis, and treatment. Cold Spring Harb Perspect Med. 2019;9: a031872.
doi: 10.1101/cshperspect.a031872
Takeda H, Matsubayashi K, Sakata H, et al. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang. 2010;99:307–13.
doi: 10.1111/j.1423-0410.2010.01362.x